secwatch / observer
8-K filed September 3, 2024, 7:59 PM ET ticker GCTK CIK 0001506983
leadership confidence high sentiment neutral materiality 0.30

Glucotrack appoints CEO Paul Goode and biotech veteran John Ballantyne to Board of Directors

Glucotrack, Inc.

item 5.02item 7.01item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Paul V. Goode

director
GCTK · Glucotrack, Inc.
Effective
2024-08-27
Filed
September 3, 2024, 7:59 PM ET
On August 27, 2024, the Board of Directors of Glucotrack, Inc. (the “Company”) appointed Paul V. Goode, and Mr. John Ballantyne to the Board of Directors (the “Board”) as board members.
Appointed

John Ballantyne

director
GCTK · Glucotrack, Inc.
Effective
2024-08-27
Filed
September 3, 2024, 7:59 PM ET
On August 27, 2024, the Board of Directors of Glucotrack, Inc. (the “Company”) appointed Paul V. Goode, and Mr. John Ballantyne to the Board of Directors (the “Board”) as board members.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Paul V. Goode was appointed as director at Glucotrack, Inc..

Action
appointed
Role
director
Exact text from the filing
On August 27, 2024, the Board of Directors of Glucotrack, Inc. (the “Company”) appointed Paul V. Goode, and Mr. John Ballantyne to the Board of Directors (the “Board”) as board members.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

John Ballantyne was appointed as director at Glucotrack, Inc..

Action
appointed
Role
director
Exact text from the filing
On August 27, 2024, the Board of Directors of Glucotrack, Inc. (the “Company”) appointed Paul V. Goode, and Mr. John Ballantyne to the Board of Directors (the “Board”) as board members.
View on SEC.gov

Glucotrack, Inc. filing history →

Source: SEC EDGAR
accession 0001493152-24-034737
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.